%0 Journal Article
%T Hemostatic Therapy for Intracerebral Hemorrhage
%A Xingxia Wang
%A Jie Gong
%A Ping Gu
%A Zhibao Zhao
%A Qingwen Jin
%J Open Journal of Modern Neurosurgery
%P 121-128
%@ 2163-0585
%D 2017
%I Scientific Research Publishing
%R 10.4236/ojmn.2017.74013
%X <b><span style=\"font-family:Verdana;\">Objective:</span></b><span style=\"font-family:;\" \"=\"\"><span style=\"font-family:Verdana;\"> To
reduce the blood pressure and elevate intracranial pressure using nimodipine
(Nimotop Intravenous (IV) infusion). Thus, intracerebral hemorrhage was
controlled, and the purpose of hemostasis was achieved. </span><b><span style=\"font-family:Verdana;\">Methods: </span></b><span style=\"font-family:Verdana;\">Sixty-eight
patients with intracerebral hemorrhage were divided into a treatment group (n =
51), and a control group (n = 35). Nimotop solution (10 mg) was administered as
a fast-flowing IV infusion in the treatment group, and 250 ml 20% mannitol
infusion was given to patients in the control group twice every day. Patients
in both groups received treatment for seven days, and the blood pressure on the
treatment day was measured. A brain Computed Tomography (CT) scan was performed
as a reexamination within two weeks. </span><b><span style=\"font-family:Verdana;\">Results:</span></b><span style=\"font-family:Verdana;\"> The blood pressure in the
treatment group was decreased from 179/104 to 151/91 mmHg, averagely, and in
the control group was decreased from 181/108 to 180/103 mmHg, averagely. The
difference between these two groups was statistically significant (</span></span><span style=\"font-family:Verdana;\"><i></i></span><i><i><span style=\"font-family:Verdana;\">P</span></i><i><span style=\"font-family:Verdana;\"></span></i></i><i><span style=\"font-family:;\" \"=\"\"> </span></i><span style=\"font-family:Verdana;\">&lt; 0.01). Hematoma enlargement occurred in 20
patients (53.3%) in the treatment group, and four patients in the control group
(8.57%). The difference between both groups was statistically significant (</span><span style=\"font-family:Verdana;\"><i></i></span><i><i><span style=\"font-family:Verdana;\">P</span></i><i><span style=\"font-family:Verdana;\"></span></i></i><i><span style=\"font-family:;\" \"=\"\"> </span></i><span style=\"font-family:;\" \"=\"\"><span style=\"font-family:Verdana;\">&lt; 0.01). There were eight deaths in the treatment
group. Seven deaths were caused by cerebral hernia, and one was caused by
complications. There was one death in the control group caused by lung
infection and gastrointestinal bleeding. </span><b><span style=\"font-family:Verdana;\">Conclusion: </span></b><span style=\"font-family:Verdana;\">Nimodipine can
dilate the arteries, reduce blood pressure, and elevate intracranial pressure,
lowering pressure gradients across vessel wall which destroy the vessel
%K Nimodipine
%K Intracerebral Hemorrhage
%K Hypertension
%K Cranial Hypertension
%U http://www.scirp.org/journal/PaperInformation.aspx?PaperID=78945